Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder

Mar 1, 2014, 00:00
10.1016/j.jval.2013.11.012
https://www.valueinhealthjournal.com/article/S1098-3015(13)04397-0/fulltext
Title : Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)04397-0&doi=10.1016/j.jval.2013.11.012
First page : 183
Section Title : Economic Evaluation
Open access? : No
Section Order : 4

Objective

A review of existing economic models in major depressive disorder (MDD) highlighted the need for models with longer time horizons that also account for heterogeneity in treatment pathways between patients. A core discrete event simulation model was developed to estimate health and cost outcomes associated with alternative treatment strategies.

Methods

This model simulated short- and long-term clinical events (partial response, remission, relapse, recovery, and recurrence), adverse events, and treatment changes (titration, switch, addition, and discontinuation) over up to 5 years. Several treatment pathways were defined on the basis of fictitious antidepressants with three levels of efficacy, tolerability, and price (low, medium, and high) from first line to third line. The model was populated with input data from the literature for the UK setting. Model outputs include time in different health states, quality-adjusted life-years (QALYs), and costs from National Health Service and societal perspectives. The codes are open source.

Results

Predicted costs and QALYs from this model are within the range of results from previous economic evaluations. The largest cost components from the payer perspective were physician visits and hospitalizations. Key parameters driving the predicted costs and QALYs were utility values, effectiveness, and frequency of physician visits. Differences in QALYs and costs between two strategies with different effectiveness increased approximately twofold when the time horizon increased from 1 to 5 years.

Conclusion

The discrete event simulation model can provide a more comprehensive evaluation of different therapeutic options in MDD, compared with existing Markov models, and can be used to compare a wide range of health care technologies in various groups of patients with MDD.

Categories :
  • Cost/Cost of Illness/Resource Use Studies
  • Cost-comparison, Effectiveness, Utility, Benefit Analysis
  • Economic Evaluation
  • Mental Health
  • Methodological & Statistical Research
  • Modeling and simulation
  • PRO & Related Methods
  • Specific Diseases & Conditions
Tags :
  • antidepressants
  • cost-effectiveness
  • depression
  • discrete event simulation
Regions :
  • Africa
  • Eastern and Central Europe
ViH Article Tags :